Effects of the Hippo signaling pathway in human gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5199-5205

  Zhou, Guang Xi ^a   Li, Xiao Yu ^a   Zhang, Qi ^a   Zhao, Kun ^a   Zhang, Cui Ping ^a   Xue, Chang Hu ^b   Yang, Kun ^a   Tian, Zi Bin ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Chronic atrophic gastritis; Gastric cancer; Hippo signaling pathway; Intestinal metaplasia

Indexed keywords

CDX2 PROTEIN, HUMAN; DNA BINDING PROTEIN; HIPPO PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; LATS1 PROTEIN, HUMAN; MACROPHAGE STIMULATING PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOPROTEIN; PHOSPHOPROTEIN; POU5F1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SCATTER FACTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAZ PROTEIN, HUMAN; TEAD1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

APOPTOSIS; ATROPHIC GASTRITIS; CARCINOMA; CASE CONTROL STUDY; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRECANCER; SIGNAL TRANSDUCTION; STOMACH TUMOR; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CASE-CONTROL STUDIES; CELL PROLIFERATION; DNA-BINDING PROTEINS; GASTRITIS, ATROPHIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; MIDDLE AGED; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; PHOSPHOPROTEINS; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84887587575     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5199     Document Type: Article

References (21)

1. Barros R, da Costa LT, Pinto-de-Sousa J, et al (2011). CDX2 auto-regulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut, 60, 290-8.
2. Chu J, Qin R, Wang N, et al (2011). Expression and significance of CDX2 and elaudin-3 in gastric carcinoma and paracancer tissue. J Clin Exp Pathol, 27, 1280-5.
3. Freund JN, Domon-Dell C, Kedinger M, Duluc I (1998). The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol, 76, 957-69.
4. Harvey KF, Pfleger CM, Hariharan IK (2003). The Drosophila Mst Ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 114, 457-67.
5. Kang JM, Lee BH, Kim N, et al (2011). CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci, 26, 647-53.
6. Liu X, Zhang X, Zhan Q, et al (2012). CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer. Cancer Biol Ther, 13, 1152-7.
7. Matsuoka J, Yashiro M, Sakurai K, et al (2012). Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res, 174, 130-5.
8. Morrow DJ, Avissar NE, Toia L, et al (2009). Pathogenesis of Barrett's esophagus: Bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophagea cells. Surgery, 146, 714-22.
9. Nishioka N, Inoue K, Adachi K, et al (2009). The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell, 16, 398-410.
10. Pan D (2010). The hippo signaling pathway in development and cancer. Dev Cell, 19, 491-505.
11. Tajima Y, Yamazaki K, Makino R, et al (2006). Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic Background. Clin Cancer Res, 12, 6469-79.
12. Trosko JE (2006). From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Ann N Y Acad Sci, 1089, 36-58.
13. Visser-Grieve S, Zhou Z, She YM, et al (2011). LATS1 Tumor suppressor is a novel actin-binding protein and negative regulator of actin polymerization. Cell Res, 21, 1513-6.
14. Wei W, Zhang C, Zhang Q, et al (2012). Expression of Hippo signaling molecules in gastric carcinogenesis. World Chin J Digestol, 20, 3027-32.
15. Wen J, Park JY, Park KH, et al (2010). Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas, 39, 622-6.
16. Xu Z, Zhu J, Zhang Q, et al (2011). A breakdown of the Hippo pathway in gastric cancer. Hepatogastroenterology, 58, 1611-7.
17. Yang L (2006). Incidence and mortality of gastric cancer in China. World J Gastroenterol, 12, 17-20.
18. Zeng Q, Hong W (2008). The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell, 13, 188-92.
19. Zhao B, Lei QY, Guan KL (2008). The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol, 20, 638-46.
20. Zhao B, Wei X, Li W, et al (2007). Inactivation of YAP onco-protein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 21, 2747-61.
21. Zheng T, Wang J, Jiang H, et al (2011). Hippo signaling in oval cells and hepatocarcinogenesis. Cancer Letters, 302, 91-9.